Updated URL for this blog: blog.frequencyfoundation.com

The final step in migrating with Google to a new URL for Dr. Jeff Sutherland's Electronic Medicine is to allow direct access at http://blog.frequencyfoundation.com.

Please update your URL for this blog to http://blog.frequencyfoundation.com

Carcinogenesis: Preventing it with electronic medicine

Bacillus licheniformis in fungus-like form. Photo by Milton Wainwright
As medical research advances, the strategy of systematically eliminating cancer cells is fine tuned. A recent clinical trial showed clearly that low voltage application of frequencies destroys cancer cells, although their approach would need significant modification to be fully effective.

There are several steps to  dealing with cancer cells:
1. Nutritional and lifestyle factors described elsewhere are critical
2. Eliminate the Rife BX BY complex
3. Eliminate the Gregory cancer virus
4. Eliminate parasites that promote tumor growth
5. Disrupt glucose metabolism of cancer cells
6. Eliminate viruses that cause malignant cells
7. Target specific malignant cells for elimination

------
There is abundant epidemiological data from all over the world on cancer incidence for a wide variety of tumors in animal and human populations. My thesis advisor was Editor of the Journal of the National Cancer Institute in the late 1970s and early 1980s. He gave me a stack of over 300 papers from the medical journals with carcinogenesis dose reponse curves for many different species. All the curves looked different. He told me to explain why they were all different and he would give me a Ph.D. I then spent about 8 years doing supercomputer mathematical analysis of data on various types of cancer. The final data set I focused in on for publication was data from the Third National Cancer Survey which had complete coverage from many states in the U.S. and was the best available data at the time. My thesis advisor had led the survey and I had complete access to all data at the National Cancer Institute.

For most human cancers, the data clearly shows a four hit process. This can be visualized most clearly in skin tumors. An abnormal cell appears and begins dividing and creates a small patch on the skin. Within this lesion, a cell mutates, and you have a small patch growing within a patch. This happens a third time, then a fourth time. On the fourth genetic change, the cell breaks through the mechanisms that control proliferation and is malignant. It grows uncontrollably in a fifth phase, with the right promoting environment available, and can get into the bloodstream and migrate to other parts of the body causing metastases.

I have repeatedly seen the frequencies 2008 and 2127 appear in myself and others after eating certain food. I have been able to confirm that this has happened in most people who have eaten a specific meal. This is the BX and BY “virus” form of Rife’s organism. Today, this is not believed to be a virus and some think it is a mycoplasma. Recent DNA sequencing of organisms found in cancer cells showed them to be a fungus.

These organisms are clearly not a typical virus. They immediately go systemic throughout the entire body. And it originally took days of repeated treatment for long periods with the FSCAN and/or EM6+ to clear the body of them. With newer technologies they can be eliminate a lot faster.

However, more and more evidence is appearing that shows cancer cell frequencies are specific frequencies in a virus sequence. It appears that a virus disrupting the cellular machinery is one of the critical steps (but not the only step) that produces a tumor. Therefore, eliminating the relevant viruses is critical to prevent ongoing appearance of pre-malignant or malignant cells.

I have repeatedly seen non-malignant skin tumors grow quickly and in one case apparently become malignant in the presence of BX and BY. In the presence of this organism it is common to have tumors erupt in less than a day. This helps to explain an interesting aspect of my previous research in carcinogenesis. In some tumors, prostate for example, the data show that the first malignant cell appears 35 years before clinical diagnosis on the average. In a fast growing tumor like lung cancer, the first malignant cell appears about a year before clinical diagnosis. However, it is very common to see people go downhill extremely quickly after initial diagnosis. While some of this is undoubtedly due to the shock of the diagnosis and resultant depression of the immune system, it is aggrevated by the BX and BY virus. Much of conventional cancer treatment does not eliminate the virus and may even promote its growth.

So the BX and BY organisms are strong promoters of at least stage 3 (premalignant) and stage 4 (malignant) tumors and may even promote earlier stages. As indicated in the paper by Owens DM, Wei S, Smart RC. A multihit, multistage model of chemical carcinogenesis. Carcinogenesis, Vol. 20, No. 9, 1837-1844, September 1999, promotion of early phases of tumor initiation increases the cellular population at risk of mutating into a subsequent phase. This process happens so fast in the presence of BX and BY that I believe the Rife organisms are both promoters and mutagens.

The first approach to stopping proliferation of tumors must be to eradicate the BX and BY virus. Parasites also release substances that promote tumor growth so they must be eliminated as well. However, they are not as dangerous as BX and BY. I believe if everyone was monitored for BX and BY and the infection was eliminated immediately, we could significantly cut cancer incidence in the U.S., probably by more than 50%.

The fact that this information has been available for almost 100 years now shows how closed mindedness and suppression of innovation has compromised American medicine. This phenomenon has largely been driven by business interests, initially by a director of the AMA who was ultimately convicted of fraud and conspiracy for suppressing cancer therapies, and in more recent years by the pharmaceutical industry.

The tumors I have worked with (lung, cervix, skin, colon) have all had the presence of BX and BY which can be eliminated straight away. It is important to realize when targeting the BX and BY organisms with an electronic device that when you kill one strain, another strain proliferates and the frequency changes. These organisms have very stable frequencies around 2008 and 2127, however, and I have seen them deviate only by 3HZ at the most. It is important to eliminate all of them and you must have the exact frequency to 1HZ and this frequency may vary between 2003-2010 and 2125-2130. In recent years, the frequency set for BX BY has expanded to hundreds of frequencies.

Eliminating the BX and BY organism does not stop cells which have already reached stage 4 and are malignant. In fact, all malignant tumors will not show BX and BY present. They can continue to proliferate and metastasize without BX and BY. The best way to eliminate the malignant cells is to stop the ATP metabolism in these cells while leaving normal cells unaffected. This will prevent mitosis and the cancer cells will die a normal death without proliferating. This appears to be possible with frequencies in the 11,700,000 range. These frequencies also seem to stop mitosis of stage 3 cells as well. The data in the Gorgun paper shows how this is possible.

Gorgun SS. Studies on the Interaction Between Electromagnetic
Fields and Living Matter Neoplastic Cellular Culture. Frontier Perspectives 7:2:44-59, Fall 1998.

Stopping cellular mitosis requires the exact frequency. I have seen frequencies in the range 11,600,000 – 11,900,000HZ affect tumors. Different tumors of the same type (or perhaps cells in different stages) will have slightly different frequencies. Metastatic tumors will have different frequencies. They must all be eliminated systematically, one by one.

I believe that Rife was able to affect a “cure” in almost every case because his device running at 11,700,000 had enough variability and harmonics to stop mitosis in all relevant cells, even though their frequencies may have been slightly different. The curse of modern technology is that it is so precise, most people are unable to reproduce Rife’s work.

Richard Loyd had a machine some years ago that could treat directly at 11,700,000HZ. Most of us are not so lucky. I have found some success, however, in using the FSCAN to treat all the octaves of the exact frequencies in the FSCAN range from 10-3,000,000HZ. More recent FSCAN devices work in the 11-12MHZ range. Current frequency sets provided to Frequency Foundation subscribers go well over 30MHZ to target viral patterns in the bodies energy field. It will be difficult but not impossible, in my view, to stop all cellular mitosis using a Rife device that can only treat at less than 10,000HZ.

These comments represent a working hypothesis that has been successful in many cases and not as successful in rapidly growing tumors. It needs further research and new data may alter the working hypothesis. I present it so that others can take a look and see if they can produce the same results consistently.
-------

Further study on cancer organims:
What is the Rife BX BY virus?
More questions on the Rife BX BY virus
More on the Rife BX BY virus and bacillus licheniformis
Gregory cancer virus
Identifying and eliminating the "cancer germ"
Origins of contemporary theory of carcinogenesis

Clinical Trial Shows Good Results Treating Cancer with Frequencies

J Exp Clin Cancer Res. 2009; 28(1): 51. Published online 2009 April 14. doi: 10.1186/1756-9966-28-51.

PMCID: PMC2672058

Copyright © 2009 Barbault et al; licensee BioMed Central Ltd.

Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of tumor-specific frequencies and assessment of a novel therapeutic approach

Alexandre Barbault,^1,2 Frederico P Costa,³ Brad Bottger,⁴ Reginald F Munden,⁵ Fin Bomholt,⁶ Niels Kuster,⁷ and Boris Pasche^1,8

¹Cabinet Médical, Avenue de la Gare 6, Lausanne, Switzerland

²Rue de Verdun 20, Colmar, France

³Sirio-Libanes Hospital, Oncology Center, São Paulo, Brazil

⁴Radiology Associates, Danbury Hospital, Danbury, CT, USA

⁵Department of Radiology, The University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL, USA

⁶SPEAG AG, Zurich, Switzerland

⁷IT'IS, Swiss Federal Institute of Technology, Zurich, Switzerland

⁸Division of Hematology/Oncology, Department of Medicine, The University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL, USA

Corresponding author.

Alexandre Barbault: alexandre.barbault@gmail.com; Frederico P Costa: fredericoperegocosta@gmail.com; Brad Bottger: bottger@optonline.net; Reginald F Munden: munden@uab.edu; Fin Bomholt: bomholt@speag.com; Niels Kuster: kuster@itis.ethz.ch; Boris Pasche: boris.pasche@ccc.uab.edu

Received January 8, 2009; Accepted April 14, 2009.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

•  Other Sections▼

Abstract

Purpose

Because in vitro studies suggest that low levels of electromagnetic fields may modify cancer cell growth, we hypothesized that systemic delivery of a combination of tumor-specific frequencies may have a therapeutic effect. We undertook this study to identify tumor-specific frequencies and test the feasibility of administering such frequencies to patients with advanced cancer.

Patients and methods

We examined patients with various types of cancer using a noninvasive biofeedback method to identify tumor-specific frequencies. We offered compassionate treatment to some patients with advanced cancer and limited therapeutic options.

Results

We examined a total of 163 patients with a diagnosis of cancer and identified a total of 1524 frequencies ranging from 0.1 Hz to 114 kHz. Most frequencies (57–92%) were specific for a single tumor type. Compassionate treatment with tumor-specific frequencies was offered to 28 patients. Three patients experienced grade 1 fatigue during or immediately after treatment. There were no NCI grade 2, 3 or 4 toxicities. Thirteen patients were evaluable for response. One patient with hormone-refractory breast cancer metastatic to the adrenal gland and bones had a complete response lasting 11 months. One patient with hormone-refractory breast cancer metastatic to liver and bones had a partial response lasting 13.5 months. Four patients had stable disease lasting for +34.1 months (thyroid cancer metastatic to lung), 5.1 months (non-small cell lung cancer), 4.1 months (pancreatic cancer metastatic to liver) and 4.0 months (leiomyosarcoma metastatic to liver).

Conclusion

Cancer-related frequencies appear to be tumor-specific and treatment with tumor-specific frequencies is feasible, well tolerated and may have biological efficacy in patients with advanced cancer.

Trial registration

clinicaltrials.gov identifier NCT00805337

Revolution in Cancer Genetics

The (r)evolution of cancer genetics
Francesca D Ciccarelli
Department of Experimental Oncology, European Institute of Oncology, IFOM-IEO Campus, Via Adamello 16, 20139 Milan, Italy

BMC Biology 2010, 8:74doi:10.1186/1741-7007-8-74
The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1741-7007/8/74

Recent advances in sequencing technologies and the launching of massive resequencing projects such as the Cancer Genome Project [1] have boosted the production of cancer genomics data. In the past few years, the entire repertoire of human exons has been sequenced in glioblastoma [2], pancreatic [3], breast and colorectal [4] cancers, and somatic mutations in selected genes have been mapped in multiple samples of renal [5] and lung [6] adenocarcinomas. In addition, the whole genomes of individuals affected by leukemia [7,8], melanoma [9], glioma [10], breast [11,12], and lung [13] cancers have been fully resequenced. All these studies have led to the identification of more than 1,000 potential cancer genes, and the list is likely to grow in the near future.

This massive amount of information will have a huge impact on our understanding of cancer genetics, even more so considering that the biological role of most mutations is still obscure. These first unbiased screenings have led to the identification of novel and unsuspected determinants of cancer, such as the isocitrate dehydrogenase enzyme genes IDH1 and IDH2, which have been found mutated in glioblastoma multiforme [2]. They have also started to question some cornerstones of cancer biology, such as the description of cancer as a unique disease driven by the somatic modification of a few key regulators. The progressive identification of novel mutated genes is expanding the 'cast of actors' [14] whose mutations might be causally involved in driving cancer. Moreover, given the high heterogeneity of genes mutated in different cancer types (Figure 1), the overall 'plot' is becoming more intricate. The emerging picture suggests that there may be distinct genetic routes to reach the common aftermath of all tumorigenic processes, which is uncontrolled cell proliferation. For example, as many as 12 core pathways are disrupted in the majority of pancreatic cancers through multiple somatic mutations [3]. This opens up an intriguing scenario where the deregulation of key pathways for tumorigenesis represents only the final step of a more general perturbation of cellular activity. The cell is seen as an integrated system in which all processes form a tightly interconnected network more than as an ensemble of independent pathways. In this context, the effect of somatic mutations occurring in the cancer genome should be interpreted in the light of their broader impact on the system's equilibrium...

Frequency Foundation Workshop - Las Vegas 10-11 July 2010

Our Vegas Frequency Foundation Workshop on July 10th & 11th is filling fast. Thanks to everyone who's given us their feedback so far. We've added many new topics you requested such as: "What local recession? How to set up a Global Remote Business right NOW!  A new paradigm for your future economic success."  Call us today to check it out and before all the $59 suites are gone!

Come to this unique and exciting workshop in futuristic self-care (pet care and more) and see for yourself why Dr. Nenah Sylver---who plan to be at the workshop and is author of The Rife Handbook of Frequency Therapy, with a Holistic Health Primer (2009)---says: “I have used Jeff Sutherland’s services for many years, sometimes for myself but mostly for my beloved dog. Jeff’s scientific knowledge and finely honed intuition helped me nurse her through cancer and Lyme-related infections, extending her life I would estimate by about six years.” Dr. Sylver will be having a book signing at the workshop.

NEWLY ADDED:  At your request, we're adding a NEW segment to the workshop to fit these economic times:  How to develop and generate income OUTSIDE of your brick and mortar business from anywhere in the world!  Not only remote clients but we'll show you how we helped other workshop attendees create frequency-based products you may never have dreamed of--so go ahead and bring your dreams with you!  We'll give you tools to develop a potentially healthy business income in ANY economy anywhere on earth.

Come join us and guest speakers, including Dr. Alan Back, for the most cutting-edge frequency research workshop ever and another guest speaker that will amaze you.  Attendees of the Frequency Foundation Workshops are put at the top of a large and growing list of inventors and researchers that wish to make this a far better world.  We are always interested in the best!

New Testimony:

"After attending Dr. Sutherland's last workshop in Kauai and learning about his remote lab set-up, I was able to eradicate my cat's bladder infection in two days! I'm so thrilled to have saved hundreds of dollars on vet bills and to have saved my precious Teddy Bear from the trauma of needles and antibiotics! Thank you, Dr. Jeff, for bringing this technology to the world and making your system duplicatable for the average person." C.F., Washington

RESERVATIONS INSTRUCTIONS:

            1.  Please call reservations at the resort (800)582-2228 (in the Continental United States) or (702)796-3322.

            2.  Please ask for reservations.

            3.  Please ask the reservations for the group block Dr. Sutherland's Frequency Foundation.  

All individuals will be responsible for their own suite, tax and incidental charges.  The Alexis Resort requires a deposit equal to one (1) night's room and tax in order to confirm reservations on a definite basis.
Any questions, please email Dale at dale.fawcett@gmail.com or call us at 360-598-6585.

Below are some of the many great comments from our last Kauai Frequency Foundation Workshop. Please e-mail Dale (dale.fawcett@gmail.com) ASAP for details for the Vegas workshop. Seating will be limited. Please include your comments as to what you wish to learn as this workshop is custom made for you. Remember to include your phone number.

'Kauai was hands down the BEST Dr. Jeff Sutherland workshop ever! I have been to several past workshops that Jeff and Dale have put together. Dr Jeff and Dale consistently surprise me by introducing the latest information on frequency medicine. The laboratory techniques and experimental data you share with us are simply wonderful. Thank you Jeff, Dale & Carol for an experience of a life time. Please let me know when another one is taking place I'm coming with bells on. I believe you mentioned the possibly of July 10th and 11th in either Vegas or San Diego? John Jacobs, Ph.D.

William Snow Ph.D. said...

Dr John is absolutely correct. We were at the workshop in Kauai also and it was the best yet! See you all in July. William Snow Ph.D.

Research on Mercury Fillings

Mercury filings are toxic and outgassing whenever they are disturbed. The mercury goes to all organ systems in your body and reduces their performance and capability. Check out this video.